Ghatnekar GS - Search Results

1

Connexin 43-Based Therapeutics for Dermal Wound Healing.

Montgomery J, Ghatnekar GS, Grek CL, Moyer KE, Gourdie RG. Montgomery J, et al. Among authors: ghatnekar gs. Int J Mol Sci. 2018 Jun 15;19(6):1778. doi: 10.3390/ijms19061778. Int J Mol Sci. 2018. PMID: 29914066 Free PMC article. Review.

2

The unstoppable connexin43 carboxyl-terminus: new roles in gap junction organization and wound healing.

Gourdie RG, Ghatnekar GS, O'Quinn M, Rhett MJ, Barker RJ, Zhu C, Jourdan J, Hunter AW. Gourdie RG, et al. Among authors: ghatnekar gs. Ann N Y Acad Sci. 2006 Oct;1080:49-62. doi: 10.1196/annals.1380.005. Ann N Y Acad Sci. 2006. PMID: 17132774 Review.

3

Novel therapies for scar reduction and regenerative healing of skin wounds.

Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG. Rhett JM, et al. Among authors: ghatnekar gs. Trends Biotechnol. 2008 Apr;26(4):173-80. doi: 10.1016/j.tibtech.2007.12.007. Epub 2008 Mar 4. Trends Biotechnol. 2008. PMID: 18295916 Review.

4

Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding.

Ghatnekar GS, O'Quinn MP, Jourdan LJ, Gurjarpadhye AA, Draughn RL, Gourdie RG. Ghatnekar GS, et al. Regen Med. 2009 Mar;4(2):205-23. doi: 10.2217/17460751.4.2.205. Regen Med. 2009. PMID: 19317641 Free PMC article.

5

A Connexin43 Mimetic Peptide Promotes Regenerative Healing and Improves Mechanical Properties in Skin and Heart.

Ongstad EL, O'Quinn MP, Ghatnekar GS, Yost MJ, Gourdie RG. Ongstad EL, et al. Among authors: ghatnekar gs. Adv Wound Care (New Rochelle). 2013 Mar;2(2):55-62. doi: 10.1089/wound.2011.0341. Adv Wound Care (New Rochelle). 2013. PMID: 24527326 Free PMC article. Review.

6

Cardiac to cancer: connecting connexins to clinical opportunity.

Grek CL, Rhett JM, Ghatnekar GS. Grek CL, et al. Among authors: ghatnekar gs. FEBS Lett. 2014 Apr 17;588(8):1349-64. doi: 10.1016/j.febslet.2014.02.047. Epub 2014 Mar 4. FEBS Lett. 2014. PMID: 24607540 Free PMC article. Review.

7

The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial.

Ghatnekar GS, Grek CL, Armstrong DG, Desai SC, Gourdie RG. Ghatnekar GS, et al. J Invest Dermatol. 2015 Jan;135(1):289-298. doi: 10.1038/jid.2014.318. Epub 2014 Jul 29. J Invest Dermatol. 2015. PMID: 25072595 Free PMC article. Clinical Trial.

8

Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.

Grek CL, Prasad GM, Viswanathan V, Armstrong DG, Gourdie RG, Ghatnekar GS. Grek CL, et al. Among authors: ghatnekar gs. Wound Repair Regen. 2015 Mar-Apr;23(2):203-12. doi: 10.1111/wrr.12275. Epub 2015 Apr 29. Wound Repair Regen. 2015. PMID: 25703647 Free PMC article. Clinical Trial.

9

Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1.

Grek CL, Rhett JM, Bruce JS, Abt MA, Ghatnekar GS, Yeh ES. Grek CL, et al. Among authors: ghatnekar gs. BMC Cancer. 2015 Apr 3;15:296. doi: 10.1186/s12885-015-1229-6. BMC Cancer. 2015. PMID: 25881004 Free PMC article.

10

Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR.

Abt MA, Grek CL, Ghatnekar GS, Yeh ES. Abt MA, et al. Among authors: ghatnekar gs. J Vis Exp. 2016 Jan 29;(107):e53329. doi: 10.3791/53329. J Vis Exp. 2016. PMID: 26862835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page